DK2024329T3 - (2R) -2 - [(4-SULPHONYL) AMINOPHENYL] PROPANAMIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
(2R) -2 - [(4-SULPHONYL) AMINOPHENYL] PROPANAMIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- DK2024329T3 DK2024329T3 DK07729254.8T DK07729254T DK2024329T3 DK 2024329 T3 DK2024329 T3 DK 2024329T3 DK 07729254 T DK07729254 T DK 07729254T DK 2024329 T3 DK2024329 T3 DK 2024329T3
- Authority
- DK
- Denmark
- Prior art keywords
- propanamids
- sulphonyl
- aminophenyl
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/09—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton the carbon skeleton being further substituted by at least two halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/14—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06114185 | 2006-05-18 | ||
| PCT/EP2007/054806 WO2007135080A2 (en) | 2006-05-18 | 2007-05-17 | (2r)-2-[(4-sulfonyl)aminophenyl]propanamides and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2024329T3 true DK2024329T3 (en) | 2013-11-04 |
Family
ID=38353147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07729254.8T DK2024329T3 (en) | 2006-05-18 | 2007-05-17 | (2R) -2 - [(4-SULPHONYL) AMINOPHENYL] PROPANAMIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US7652169B2 (en) |
| EP (1) | EP2024329B1 (en) |
| JP (1) | JP5161873B2 (en) |
| KR (1) | KR101422299B1 (en) |
| CN (1) | CN101448784B (en) |
| AU (1) | AU2007253424B2 (en) |
| BR (1) | BRPI0712064B8 (en) |
| CA (1) | CA2649794C (en) |
| CY (1) | CY1114532T1 (en) |
| DK (1) | DK2024329T3 (en) |
| ES (1) | ES2433095T3 (en) |
| HR (1) | HRP20130989T1 (en) |
| IL (1) | IL194939A (en) |
| MX (1) | MX2008013957A (en) |
| NZ (1) | NZ572075A (en) |
| PL (1) | PL2024329T3 (en) |
| PT (1) | PT2024329E (en) |
| RS (1) | RS53007B (en) |
| RU (1) | RU2457201C2 (en) |
| SI (1) | SI2024329T1 (en) |
| WO (1) | WO2007135080A2 (en) |
| ZA (1) | ZA200808907B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2166006A1 (en) * | 2008-09-18 | 2010-03-24 | Dompe' S.P.A. | 2-aryl-propionic acids and derivatives and pharmaceutical compositions containing them |
| KR101298651B1 (en) * | 2011-03-16 | 2013-08-21 | 연세대학교 산학협력단 | Pharmaceutical Compositions for Enhanced Anti-angiogenic Activities |
| CN103159674A (en) * | 2013-04-03 | 2013-06-19 | 苏州安诺生物医药技术有限公司 | 2-benzene alkyl amid compound and preparation method, medical composition and use thereof |
| US10301378B2 (en) | 2013-06-18 | 2019-05-28 | New York University | Cellular factors involved in the cytotoxicity of Staphylococcus aureus leukocidins: novel therapeutic targets |
| RU2017106172A (en) * | 2014-07-31 | 2018-08-28 | Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед | USE OF CXCR2 ANTAGONISTS TO PREVENT AND / OR TREAT PERIPHERAL NEUROPATHY CAUSED BY CHEMOTHERAPY (CIPN) |
| WO2021191305A1 (en) | 2020-03-26 | 2021-09-30 | Dompe' Farmaceutici Spa | Cxcl8 inhibitors for use in the treatment of covid-19 |
| EP3884932A1 (en) | 2020-03-26 | 2021-09-29 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
| EP4008325A1 (en) | 2020-12-02 | 2022-06-08 | Dompe' Farmaceutici S.P.A. | Cxcl8 inhibitors for use in the treatment of covid-19 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN188162B (en) * | 1999-02-05 | 2002-08-31 | Torrent Pharmaceuticals Ltd | |
| IT1317826B1 (en) * | 2000-02-11 | 2003-07-15 | Dompe Spa | AMIDES, USEFUL IN THE INHIBITION OF THE CHEMOTAXIS OF NEUTROPHILES INDUCED BY IL-8. |
| ITMI20012434A1 (en) * | 2001-11-20 | 2003-05-20 | Dompe Spa | 2-ARYL-PROPIONIC ACIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| EP1457485A1 (en) * | 2003-03-14 | 2004-09-15 | Dompé S.P.A. | Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| KR100707123B1 (en) * | 2003-07-02 | 2007-04-16 | 그뤼넨탈 게엠베하 | 4-methylsulfonylaminophenyl analogues as vanilloid antagonist showing excellent analgesic activity and the pharmaceutical composition containing the same |
| ATE444286T1 (en) * | 2004-03-23 | 2009-10-15 | Dompe Pha R Ma Spa Res & Mfg | 2-PHENYLPROPIONIC ACID DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
| AU2005315591B2 (en) * | 2004-12-15 | 2011-03-17 | Dompe' Farmaceutici S.P.A. | 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
-
2007
- 2007-05-17 PT PT77292548T patent/PT2024329E/en unknown
- 2007-05-17 HR HRP20130989TT patent/HRP20130989T1/en unknown
- 2007-05-17 KR KR1020087027557A patent/KR101422299B1/en active Active
- 2007-05-17 WO PCT/EP2007/054806 patent/WO2007135080A2/en not_active Ceased
- 2007-05-17 EP EP07729254.8A patent/EP2024329B1/en active Active
- 2007-05-17 BR BRPI0712064A patent/BRPI0712064B8/en active IP Right Grant
- 2007-05-17 US US12/227,519 patent/US7652169B2/en active Active
- 2007-05-17 SI SI200731344T patent/SI2024329T1/en unknown
- 2007-05-17 DK DK07729254.8T patent/DK2024329T3/en active
- 2007-05-17 JP JP2009510463A patent/JP5161873B2/en active Active
- 2007-05-17 CN CN2007800179024A patent/CN101448784B/en active Active
- 2007-05-17 CA CA2649794A patent/CA2649794C/en active Active
- 2007-05-17 RS RS20130467A patent/RS53007B/en unknown
- 2007-05-17 ES ES07729254T patent/ES2433095T3/en active Active
- 2007-05-17 RU RU2008149936/04A patent/RU2457201C2/en active
- 2007-05-17 MX MX2008013957A patent/MX2008013957A/en active IP Right Grant
- 2007-05-17 ZA ZA200808907A patent/ZA200808907B/en unknown
- 2007-05-17 AU AU2007253424A patent/AU2007253424B2/en active Active
- 2007-05-17 NZ NZ572075A patent/NZ572075A/en unknown
- 2007-05-17 PL PL07729254T patent/PL2024329T3/en unknown
-
2008
- 2008-10-27 IL IL194939A patent/IL194939A/en active IP Right Grant
-
2009
- 2009-12-15 US US12/653,599 patent/US7868046B2/en active Active
-
2013
- 2013-10-25 CY CY20131100949T patent/CY1114532T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1400051I1 (en) | Pharmaceutical composition containing lurazidone | |
| ITBO20050123A1 (en) | GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA | |
| DK1913001T3 (en) | (R) -N-METHYLNALTREXON, METHODS OF SYNTHESIS AND PHARMACEUTICAL APPLICATION | |
| IL190292A (en) | Pyridopyrimidinone derivatives and pharmaceutical compositions comprising them | |
| IL238308B (en) | Pharmaceutical compositions containing azelastine | |
| PL2939688T3 (en) | Pharmaceutical compositions containing botulinum neurotoxin | |
| IL197836A (en) | Phlorizin analogs and pharmaceutical compositions comprising them | |
| BRPI0511900A (en) | pharmaceutical compositions | |
| NO20075628L (en) | Pharmaceutical formulations | |
| IL194546A0 (en) | Arylaminopyridine derivatives and pharmaceutical compositions containing them | |
| IL187957A0 (en) | Liquid pharmaceutical formulations of docetaxel | |
| DK2024329T3 (en) | (2R) -2 - [(4-SULPHONYL) AMINOPHENYL] PROPANAMIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| IL187748A0 (en) | Pharmaceutical compositions containing misoprostal | |
| EP2001400A4 (en) | ORAL PREPARATIONS OF GLYCYL-2-METHYLPROPYL-GLUTAMATE | |
| IL187534A0 (en) | Thiazole derivatives, use thereof and pharmaceutical compositions containing them | |
| PT1850664E (en) | FORMULATION OF CAPSULES | |
| IL218745A0 (en) | Pharmaceutical compositions containing roflumilast | |
| IL187552A0 (en) | Pharmaceutical compositions containing nebivolol | |
| DK2038294T3 (en) | 18-methyl-19-nor-androst-4-ene-17,17-spiro ether (18-methyl-19-nor-20-spirox-4-ene-3-one) and pharmaceutical compositions containing these | |
| EP1890677A4 (en) | Pharmaceutical compositions and use thereof | |
| PL1951663T3 (en) | (r)-arylkylamino derivatives and pharmaceutical compositions containing them | |
| DK2094638T3 (en) | 2-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them | |
| IL187026A0 (en) | Substituted acrylamide derivatives and pharmaceutical compositions containing the same | |
| DK1707564T3 (en) | Indanyl-piperazine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| DK1745786T3 (en) | Neuroprotective compounds and pharmaceutical compositions comprising them |